CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing disruptive technologies and products based on its proprietary, non-animal recombinant human collagen ...

Researchers in Germany have made a great breakthrough that could potentially revolutionize the future of regenerative ...

New York Tech and UC Irvine develop a 3D-printed human colon model to advance cancer drug testing and gastrointestinal ...

October is Breast Cancer Awareness Month and, according to the American Cancer Society, in this year alone more than 316,000 US women are projected to be diagnosed with an invasive ...

"Organoids are set to become essential tools in medical research. The research program financed by SATT AxLR and the support of CTIBIOTECH, in this key stage, will enable Cilcare to accelerate the ...

Cancer models retaining original tumor characteristics can be developed through 3D bioprinting, allowing for rapid evaluation of drug responses. A team of researchers led by Jinah Jang from Pohang ...

Brazilian cosmetics giant Grupo Boticário has developed an engineered type of skin to transform the way cosmetics are tested and pave the way for advancements in regenerative medicine. Described as a ...

Recently, nanoparticle-driven 3D bioprinting has emerged as a revolutionary approach for high-throughput drug screening, offering enhanced scalability, accuracy, and efficiency while reducing reliance ...

investigation into the onset mechanism of brain metastasis based on cerebral vascular curvature. Reproduced with permission from Nature Communications (link: https ...

October is Breast Cancer Awareness Month, and this year alone, more than 316,000 women in the U.S. are projected to be diagnosed with an invasive form of the disease, according to the American Cancer ...